research emerging

Setmelanotide

metabolic

The phase 3 TRANSCEND trial found large BMI and hunger reductions with setmelanotide in acquired hypothalamic obesity, alongside a substantial adverse-event burden.

Research status: research emerging

Deep Dives on Setmelanotide

Start here for the plain-English articles connected to this peptide.

metabolic9 min read

Setmelanotide and Hypothalamic Obesity: What the Phase 3 Trial Actually Shows

The phase 3 TRANSCEND trial found large BMI and hunger reductions with setmelanotide in acquired hypothalamic obesity, alongside a substantial adverse-event burden.

Read article

Quick Facts

Origin: Peptide topic covered by the article "Setmelanotide and Hypothalamic Obesity: What the Phase 3 Trial Actually Shows"
Amino acids
Category: metabolic

Mechanisms

Discussed in relation to setmelanotide hypothalamic obesity research
Evidence quality varies by claim and should be separated from consumer marketing
Clinical relevance, safety, and long-term effects may remain uncertain

Research Areas